| 2026-06-09 17:13 |
8-K |
["5.02"] |
officer change |
0.52
|
Interim CEO compensation award suggests extended CEO search; potential M&A signal if search includes strategic alternatives. |
SEC · detail |
| 2026-06-01 18:35 |
8-K |
["8.01", "9.01"] |
other |
0.05
|
Teleflex announces debt refinancing via $500M senior notes offering; no M&A signals. |
SEC · detail |
| 2026-06-01 07:59 |
8-K |
["7.01", "8.01", "9.01"] |
other |
0.15
|
Teleflex announces $500M Senior Notes offering to refinance existing debt; mentions prior Biotronik VI acquisition and strategic divestitures but no M&A activity in progress. |
SEC · detail |
| 2026-05-27 17:23 |
8-K |
["1.01", "2.03", "9.01"] |
other |
0.05
|
Teleflex refinanced credit facility with JPMorgan and syndicate; standard corporate financing unrelated to M&A. |
SEC · detail |
| 2026-05-20 16:14 |
8-K |
["5.07"] |
other |
0.00
|
Routine annual shareholder meeting voting results; no M&A signals present. |
SEC · detail |
| 2026-05-07 07:04 |
8-K |
["2.02", "7.01", "9.01"] |
other |
0.15
|
Routine Q1 2026 earnings announcement with strategic divestitures and prior acquisition disclosures; no M&A signals. |
SEC · detail |
| 2026-04-30 16:30 |
8-K |
["5.02"] |
officer change |
0.25
|
New CEO appointment from Medtronic with robust change-of-control severance; weak M&A signal absent strategic review language. |
SEC · detail |